SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

Sunesis Pharmaceuticals Q3 EPS $(0.29) Beats $(0.34) Estimate

Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.34) by 14.71 percent. This is a 383.33 percent decrease over losses of $(0.06) per

· 11/16/2020 16:11
Sunesis Pharmaceuticals (NASDAQ:SNSS) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.34) by 14.71 percent. This is a 383.33 percent decrease over losses of $(0.06) per share from the same period last year.